Participants
| Role | Name | HCID | Charge |
|---|
| Reactant | Chloroacetonitrile | HCID 7856 | — |
| Reactant | Sodium hydride | HCID 24758 | — |
| Reactant | Benzyl (2-oxo-5-phenyl-2,3-dihydro-1h-benzo[e][1,4]diazepin-3-yl)carbamate | HCID 2756242 | — |
| Solvent | Dimethylformamide | HCID 6228 | — |
| Product | HCID 9979758 | HCID 9979758 | 93% |
Reaction Steps
1,3-Dihydro-3(R,S)-[(benzyloxycarbonyl)amino]-5-phenyl-2H-1,4-benzodiazepin-2-one (1.5 g) was dissolved in 25 ml of dry N,N-dimethylformamide at 0° C. To this solution was added 218 mg of (60%) sodium hydride and the resulting reaction mixture was stirred for 15 minutes. Chloroacetonitrile in 1 ml of dry N,N-dimethylformamide was then added and the reaction mixture was allowed to warm to room temperature. After 1 hour the reaction mixture was concentrated under reduced pressure and the residue was partitioned between ethyl acetate and 10% citric acid solution. The organic phase was washed with brine, then dried (sodium sulfate), and concentrated to give a solid. The title compound (1.53 g, 93%) was obtained in pure form after flash silica gel chromatography employing ethyl acetate-hexane (1:2 v/v) as eluant.
Provenance & Evidence
| DOI | 10.6084/m9.figshare.5104873.v1 |
|---|
| Patent number | US05218114 |
|---|
| Source dataset | uspto-grants-1993_06 |
|---|
| ORD ID | ord-65562908051b4c8f8823710359019b1b |
|---|
| Source note | uspto-grants-1993_06 |
|---|